Gene: ZC3H13
Official Full Name: zinc finger CCCH-type containing 13provided by HGNC
Gene Summary: Enables RNA binding activity. Involved in mRNA processing. Located in nuclear speck. Part of RNA N6-methyladenosine methyltransferase complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29884 | ZC3H13 Knockout cell line (HeLa) | Human | ZC3H13 | 1:3~1:6 | Negative | Online Inquiry |
KO29885 | ZC3H13 Knockout cell line (HCT 116) | Human | ZC3H13 | 1:2~1:4 | Negative | Online Inquiry |
KO29886 | ZC3H13 Knockout cell line (HEK293) | Human | ZC3H13 | 1:3~1:6 | Negative | Online Inquiry |
KO29887 | ZC3H13 Knockout cell line (A549) | Human | ZC3H13 | 1:3~1:4 | Negative | Online Inquiry |
ZC3H13 Gene Knockout Cell Lines are specialized cellular models engineered to lack the expression of the ZC3H13 gene, a critical regulator of various cellular processes, including RNA metabolism and gene expression modulation. Using advanced CRISPR-Cas9 technology, these cell lines provide researchers with a robust tool for elucidating the functional role of ZC3H13 in both normal physiology and disease states. By selectively knocking out the ZC3H13 gene, these lines facilitate the study of downstream pathways and interactions, helping to clarify the gene's involvement in oncogenesis, immune response, and genomic stability.
Key to their appeal is the precise knockout mechanism that offers a clear, reproducible approach for investigating gene function within a controlled environment. Researchers can employ these cell lines in a range of applications, from fundamental research that explores the biology of ZC3H13 to clinical studies aiming to uncover novel therapeutic targets in diseases such as cancer. Additionally, they serve as an invaluable resource for pharmacological screening and the development of gene therapy strategies.
What differentiates ZC3H13 Gene Knockout Cell Lines from alternative models is their specificity and the high efficiency of gene disruption, which leads to pronounced phenotypic changes, making the observations more apparent and meaningful. Furthermore, these cell lines are ready-to-use, reducing the time and resources typically required for cell line development.
The value of ZC3H13 Gene Knockout Cell Lines extends beyond their immediate application in laboratory settings; they empower researchers and clinicians to gain deeper insights into gene function and regulation. As a result, these cell lines are indispensable for driving innovation in genetic research and therapeutic developments. Our company is committed to delivering high-quality biological research tools, backed by extensive expertise in gene editing technologies, ensuring that researchers have the resources necessary to advance their work successfully.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.